bioMérieux, EN

Midsection of male doctor putting oxygen mask ventilator on sick mixed race girl in hospital bed

• Image provider: Adobe Stock
• Image ID: 430373872
• License: Extended use

Protecting Health During Respiratory Season

Respiratory illnesses affect millions of lives each year, putting vulnerable patients and communities at greater risk. Timely, accurate diagnostic information helps support faster responses, informed care decisions, and stronger public health preparedness.

Explore Respiratory Resources

Young nurse in ICU carefully checking the vitals of an unconscious patient, demonstrating dedication and care in a high-stress medical environment.

• Image provider: Adobe Stock
• Image ID: 836415604
• License: Extended use

Sepsis Awareness: Advancing Timely Diagnosis

Sepsis is a medical emergency requiring rapid recognition and timely intervention. Identifying signs and symptoms before an emergency can make a critical difference. Explore resources, expert perspectives and insights highlighting the role of diagnostics in supporting patient care.

Explore Sepsis Resources

Progress Toward a More Sustainable Future

From reducing emissions and preserving resources to promoting eco-design, our teams take concrete actions across the globe to support environmental sustainability while advancing our mission to improve public health.

Discover how we drive change.

Supporting Ebola Response: Rapid Diagnostics and Global Expertise

Advancing our commitment to public health, our teams are partnering to actively support Ebola response efforts on the ground, expand diagnostic testing and strengthen laboratory capabilities.

Explore the Ebola Resource Hub

News

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE^® SPOTFIRE^® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

bioMérieux's BIOFIRE® SPOTFIRE® Vaginitis (VG) Panel has received Dual 510(k) Clearance and CLIA Waiver* from the U.S. Food and Drug Administration (FDA).

Discover more

Swipe for more stories

WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

bioMérieux, a world leader in in vitro diagnostics, announced that the World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the BIOFIRE® Global Fever Special Pathogens Panel, strengthening access to differential diagnostic testing in support of the ongoing Ebola Bundibugyo outbreak affecting the Democratic Republic of the Congo (DRC) and neighboring countries.

Discover more
bioMérieux Launches SPINCHIP^® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies

Marcy-l’Étoile (France), September 24, 2026 – bioMérieux, a global leader in in vitro diagnostics, today announced the launch of SPINCHIP®, an innovative point-of-care platform, featuring its first test for the measurement of high-sensitivity cardiac troponin I from a single drop of blood: SPINCHIP® hs-cTnl. Presented at the European Society of Emergency Medicine (EUSEM) Congress in Paris, this rapid diagnostic solution will initially be available in Europe, bringing a critical test closer to the point of care and helping emergency teams quickly triage adult patients with suspected acute myocardial infarction.

Discover more
bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

bioMérieux, a world leader in the field of in vitro diagnostics, announced that its BIOFIRE® Respiratory 2.1 plus (RP2.1plus) Panel and BIOFIRE® FILMARRAY® Pneumonia plus (PNplus) Panel have received CE marking under the IVDR* as Class D in vitro diagnostic devices, the highest risk classification under the regulation. The classification is driven by the inclusion of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) on both test menus.

Discover more

Enabling Decision-Making

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

As an antimicrobial steward

BE A GAME CHANGER

You can help sustain antibiotic efficacy for future generations with the right diagnostic tests to guide appropriate antibiotic therapy.

Discover More

SEPSIS WAITS FOR NO ONE

Put the right answers in the clinician's hands.
Deliver the actionable insights needed for timely sepsis management.

Learn More

As a protector of consumer health

BE A GAME CHANGER

When you select a diagnostic partner you can trust, manufacturing safe food and beverages comes with confidence.

Discover more

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

By choosing the right partner and diagnostics solutions you can manufacture safer products, giving you confidence in the quality of your offer.

Discover more

In respiratory infections, including COVID-19

BE A GAME CHANGER

To make sure your patients don’t miss a breath, you need a partner you can count on. bioMérieux offers a comprehensive range of diagnostic tools enabling various RESPIRATORY linked infections, including primary diagnosis of SARS-CoV-2 you can rely on.

ANTIMICROBIAL STEWARDSHIP
SEPSIS
FOOD SAFETY & QUALITY
PHARMA QUALITY CONTROL
COVID-19

VITEK^® REVEAL™

The newest addition to our Sepsis Solution, VITEK^® REVEAL™ offers fast AST results to effectively and efficiently manage bloodstream infections.

VIDAS^® KUBE™

VIDAS^® KUBE™ is designed to preserve everything labs appreciate about the VIDAS^® Solution combined with advanced technology. VIDAS^® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.

BIOFIRE^® FILMARRAY^® TORCH

Syndromic infectious disease testing with BIOFIRE^® FILMARRAY^® TORCH is the fastest way to better results.

VITEK^® MS PRIME

VITEK^® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.

BIOFIRE^® SPOTFIRE^® System

The BIOFIRE SPOTFIRE System combines BIOFIRE’s high-multiplex PCR expertise with smart design to deliver fast, reliable results.

With sample preparation and system setup completed in under 5 minutes, BIOFIRE SPOTFIRE enables syndromic testing across up to 4 modules and delivers automated results within a timeframe aligned with a typical patient visit. This efficiency may empower clinicians to make faster, more informed decisions at the Point of Care.

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels

The BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels enable testing for respiratory pathogens from either a nasopharyngeal swab, a throat swab or an anterior nasal swab, providing a flexible respiratory solution across all the continuum of care settings.

Respiratory Tract Infections

When a patient is suffering from respiratory symptoms, it’s challenging to know what’s causing the illness without diagnostic results. Our respiratory solutions provide fast, comprehensive, and accurate answers for optimized patient care.

GENE-UP^®

GENE-UP® delivers a Real-Time PCR technology for the detection of foodborne pathogens, spoilers and viruses; simplifying training and workflow and reducing cross contamination risk.

GENE-UP^® TYPER

GENE UP® TYPER is a real-time PCR assay using probabilistic typing of specific microorganisms to help identify the root cause of contamination and avoid future recurrence.

VIDAS KUBE close-up in a lab with technician hands preparing and handling sample

VIDAS KUBE, Food Safety and Quality, Pathogen Detection

VIDAS^® KUBE™ Automated Food Pathogens Detection

VIDAS® KUBE™ is an automated food pathogen detection system with accessible volume flexibility adding advanced automation, minimum training and higher productivity.

TEMPO^® Quality Indicator Solution

TEMPO® is a fully automated enumeration system that tests quality indicators in food products and environmental samples within your own laboratory.

ENDONEXT^™Solutions

The ENDONEXT™ portfolio offers innovative and more sustainable recombinant reagents to simplify endotoxin testing while reducing hands‑on time and waste.

BIOFIRE^® Mycoplasma

BIOFIRE® Mycoplasma is a fully automated system, ensuring easy in-house mycoplasma detection results inunder an hour in testing raw materials and final product release.

3P^® ENTERPRISE

3P® ENTERPRISE delivers a full workflow automation with real‑time oversight, data integrity, and cross‑site harmonization to boost efficiency in environmental monitoring programs.

VITEK^®MS PRIME

VITEK® MS PRIME is the next level of automated MALDI-TOF Mass Spectrometry system, that allows an accurate microbial identification to the species-level.

Planting a family tree. Hands of grandfather and little boy planting young tree in the garden. Environmental awareness. Spring concept, save nature and care.

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

This dedication to public health is the thread that connects everything we do. It connects us to our history - since 1963, we have been fulfilling the vision of the Mérieux family to improve health, while maintaining the values of respect, accountability, transparency, and sharing. 

Discover more

Protecting Health During Respiratory Season

Sepsis Awareness: Advancing Timely Diagnosis

Progress Toward a More Sustainable Future

Supporting Ebola Response: Rapid Diagnostics and Global Expertise

News

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

bioMérieux Launches SPINCHIP® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies

bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

Enabling Decision-Making

As an antimicrobial steward

BE A GAME CHANGER

SEPSIS WAITS FOR NO ONE

As a protector of consumer health

BE A GAME CHANGER

In ensuring quality pharmaceutical goods

BE A GAME CHANGER

In respiratory infections, including COVID-19

BE A GAME CHANGER

Featured Products

VITEK® REVEAL™

VIDAS® KUBE™

BIOFIRE® FILMARRAY® TORCH

VITEK® MS PRIME

BIOFIRE® SPOTFIRE® System

BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels

Respiratory Tract Infections

GENE-UP®

GENE-UP® TYPER

VIDAS® KUBE™ Automated Food Pathogens Detection

TEMPO® Quality Indicator Solution

ENDONEXT™ Solutions

BIOFIRE® Mycoplasma

3P® ENTERPRISE

VITEK® MS PRIME

Our purpose

WE HELP MAKE THE WORLD A HEALTHIER PLACE

bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE^® SPOTFIRE^® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

bioMérieux Launches SPINCHIP^® hs-cTnl, a Major Innovation for the Measurement of High-Sensitivity Cardiac Troponin I and Faster Management of Cardiac Emergencies

VITEK^® REVEAL™

VIDAS^® KUBE™

BIOFIRE^® FILMARRAY^® TORCH

VITEK^® MS PRIME

BIOFIRE^® SPOTFIRE^® System

BIOFIRE^® SPOTFIRE^® Respiratory/Sore Throat (R/ST) Panels & Respiratory/Sore Throat plus (R/STplus) Panels

GENE-UP^®

GENE-UP^® TYPER

VIDAS^® KUBE™ Automated Food Pathogens Detection

TEMPO^® Quality Indicator Solution

ENDONEXT^™Solutions

BIOFIRE^® Mycoplasma

3P^® ENTERPRISE

VITEK^®MS PRIME